The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases. Source link
Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to…
Drug regulators said they have received several reports of suspected suicidal and self-injurious behavior in patients taking the drugs. Source…
The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link
Swings in Ireland’s pharmaceutical industry, often rooted in tax moves by U.S.-based firms, have outsize impact on European output. Source…
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share. Source link
The plant in Rocky Mount, N.C., produces a quarter of the sterile injectable medicines used by U.S. hospitals. Source link
A surprisingly early distribution and a stretched valuation hit J&J’s consumer health arm hard. Source link
The activist is pushing for a shake-up of the contract drug manufacturer’s board. Source link